ArticleAnnals of surgical oncology2023

The Predictive Utility of MammaPrint and BluePrint in Identifying Patients with Locally Advanced Breast Cancer Who are Most Likely to Have Nodal Downstaging and a Pathologic Complete Response After Neoadjuvant Chemotherapy.

Peter Blumencranz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.